Back to search

The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials

Data up to Jan 2025

Published2008
Citations241
References50

Total Citations Per Year

Abstract

References (50)

Prevalence of Overweight and Obesity in the United States, 1999-2004

2006 • 8,878 citations

Abdominal obesity and metabolic syndrome

2006 • 4,004 citations

The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population

2004 • 2,625 citations

Prevalence of a Metabolic Syndrome Phenotype in Adolescents

2003 • 2,295 citations

Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

1989 • 1,858 citations

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

2007 • 981 citations

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1992 • 908 citations

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

2003 • 775 citations

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

1995 • 647 citations

Effects of Lifestyle Activity vs Structured Aerobic Exercise in Obese Women<SUBTITLE>A Randomized Trial</SUBTITLE>

1999 • 630 citations

Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction

1997 • 606 citations

Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay

1988 • 538 citations

Adolescent Overweight and Future Adult Coronary Heart Disease

2007 • 526 citations

Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women

2000 • 515 citations

Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone1

1999 • 475 citations

Epidemiology and Adverse Cardiovascular Risk Profile of Diagnosed Polycystic Ovary Syndrome

2006 • 378 citations

Impact of Obesity on the Risk for Polycystic Ovary Syndrome

2007 • 376 citations

Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet

2003 • 345 citations

Ovarian Function and Metabolic Factors in Women with Oligomenorrhea Treated with Metformin in a Randomized Double Blind Placebo-Controlled Trial

2002 • 342 citations

The role of lifestyle modification in polycystic ovary syndrome

2002 • 328 citations

Development of polycystic ovary syndrome: involvement of genetic and environmental factors

2005 • 295 citations

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study

2004 • 270 citations

Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease

2005 • 269 citations

Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay

1988 • 262 citations

Obesity and Sex Steroid Changes across Puberty: Evidence for Marked Hyperandrogenemia in Pre- and Early Pubertal Obese Girls

2006 • 240 citations

Overweight and obesity from childhood to adulthood: a follow‐up of participants in the 1985 Australian Schools Health and Fitness Survey

2007 • 239 citations

Altered Vascular Function in Young Women with Polycystic Ovary Syndrome

2002 • 236 citations

Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy

2001 • 232 citations

Type 2 Diabetes Mellitus in Children

2001 • 182 citations

Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity

2004 • 173 citations

The Association of Obesity and Hyperandrogenemia during the Pubertal Transition in Girls: Obesity as a Potential Factor in the Genesis of Postpubertal Hyperandrogenism

2006 • 172 citations

Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives

2005 • 163 citations

A Comparison of Lipid Variables as Predictors of Cardiovascular Disease in the Asia Pacific Region

2005 • 149 citations

The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors

2008 • 148 citations

Insulin Resistance, the Metabolic Syndrome, Diabetes, and Cardiovascular Disease Risk in Women with PCOS

2006 • 138 citations

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

2002 • 136 citations

Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program

2007 • 124 citations

Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome

2006 • 102 citations

Role of lifestyle modification in the management of polycystic ovary syndrome

2006 • 92 citations

Randomized Controlled Trial Evaluating Response to Metformin Versus Standard Therapy in the Treatment of Adolescents with Polycystic Ovary Syndrome

2005 • 90 citations

Cardiometabolic features of polycystic ovary syndrome

2008 • 87 citations

Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic Disease

1995 • 81 citations

Obesity—A Critical Issue in Preventive Cardiology: The Bogalusa Heart Study

2005 • 71 citations

Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-reactive Protein and Homocysteine in Young Women

2008 • 68 citations

Body Mass Index in Adolescence and Number of Children in Adulthood

2007 • 59 citations

Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment

2008 • 51 citations

Combined Oral Contraceptive Treatment of Adolescent Girls with Polycystic Ovary Syndrome: Lipid Profile

2000 • 46 citations

Metformin Beyond Diabetes: New Life for an Old Drug

2006 • 43 citations

Oral Contraceptives and the Management of Hyperandrogenism–Polycystic Ovary Syndrome in Adolescents

2005 • 36 citations

Which Treatment Options Should Be Used in Adolescents with Polycystic Ovary Syndrome?

2004 • 5 citations

Cited By (0)

Loading...